Tki

Mechanisms of TKI resistance 4:44
Mechanisms of TKI resistance

European Society for Medical Oncology (ESMO) 5,754 6 years ago
ORANG JAKARTA SAJA KECAM PERANTAU KENAPA HARUS MELARANG TKI MALAYSIA UCAPKAN INI 28:07
ORANG JAKARTA SAJA KECAM PERANTAU KENAPA HARUS MELARANG TKI MALAYSIA UCAPKAN INI

toha channel 13,885 15 hours ago
Henok Tekle Wari - Tki ትኪ - New Eritrean Comedy 2018 24:28
Henok Tekle Wari - Tki ትኪ - New Eritrean Comedy 2018

Jayo Truth 389,184 5 years ago
The challenges associated with long-term TKI use in patients with CML 1:12
The challenges associated with long-term TKI use in patients with CML

VJHemOnc – Video Journal of Hematology & HemOnc 249 1 year ago
MODUS PENIPUAN BARU DI DEPAN KABAH ‼️20 TAHUN JADI TKI DI SAUDI ORANG INI BONGKAR SEMUANYA - Alman 1:16:30
MODUS PENIPUAN BARU DI DEPAN KABAH ‼️20 TAHUN JADI TKI DI SAUDI ORANG INI BONGKAR SEMUANYA - Alman

kasisolusi 2,821,455 3 weeks ago
Current CML treatments which TKI to choose? 2:17
Current CML treatments which TKI to choose?

VJHemOnc – Video Journal of Hematology & HemOnc 698 5 years ago
Dosing Strategies for Managing TKI-Related Side Effects 2:43
Dosing Strategies for Managing TKI-Related Side Effects

OncLive 324 9 years ago
Tetris Tutorial - Basic Openers incl. PCO TKI and DT Cannon 7:08
Tetris Tutorial - Basic Openers incl. PCO TKI and DT Cannon

GoTron88 3,875 2 years ago
Treatment of CML with TKI’s 2:46
Treatment of CML with TKI’s

PfizerBelgium 883 1 year ago
Efficacy & tolerability of available TKI therapies in CML & managing TKI resistance 6:22
Efficacy & tolerability of available TKI therapies in CML & managing TKI resistance

VJHemOnc – Video Journal of Hematology & HemOnc 58 1 year ago
Frontline TKI Strategies in Kidney Cancer 4:49
Frontline TKI Strategies in Kidney Cancer

OncLive 367 6 years ago
The reality of implementing TKI therapies for NSCLC in Europe 1:17
The reality of implementing TKI therapies for NSCLC in Europe

VJOncology 50 5 years ago
Emerging therapeutic approaches for TKI-resistant CML 1:39
Emerging therapeutic approaches for TKI-resistant CML

VJHemOnc – Video Journal of Hematology & HemOnc 120 2 years ago
Understanding the cause of TKI resistance to improve management strategies in CML 2:45
Understanding the cause of TKI resistance to improve management strategies in CML

VJHemOnc – Video Journal of Hematology & HemOnc 153 1 year ago
Dr. Michael Mauro on Toxicities of TKI Usage in CML Patients 1:07
Dr. Michael Mauro on Toxicities of TKI Usage in CML Patients

Targeted Oncology 378 8 years ago
Targeting TKI-resistant CML with LY3009120 and asciminib 2:40
Targeting TKI-resistant CML with LY3009120 and asciminib

VJHemOnc – Video Journal of Hematology & HemOnc 362 2 years ago
The Feasibility of TKI Discontinuation 7:45
The Feasibility of TKI Discontinuation

OncLive 208 9 years ago
Which TKI-chemo-HSCT cocktail for Ph+ ALL? 3:11
Which TKI-chemo-HSCT cocktail for Ph+ ALL?

VJHemOnc – Video Journal of Hematology & HemOnc 161 3 years ago

Now looking for